Park Ha Biological (PHH) independent director Da Yang steps down

Rhea-AI Filing Summary

Park Ha Biological Technology Co., Ltd. reported that independent director Mr. Da Yang resigned from the board, effective August 25, 2025. The company states that his resignation was not due to any disagreement with its operations, policies, or procedures, indicating this is presented as a non-controversial board change. The report is signed on behalf of the company by Chief Executive Officer and Chairperson of the Board, Xiaoqiu Zhang.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2025

Commission File Number: 001-42453

Park Ha Biological Technology Co., Ltd.

901, Building C, Phase 2

Wuxi International Life Science Innovation Campus
196 Jinghui East Road

Xinwu District, Wuxi, Jiangsu Province
People’s Republic of China 214000

+86 400 012 7562

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒        Form 40-F ☐

On August 25, 2025, Mr. Da Yang tendered his resignation as an independent director of Park Ha Biological Technology Co., Ltd. (the “Company”), effective August 25, 2025. Mr. Da Yang’s resignation was not a result of any disagreement with the Company’s operations, policies or procedures.

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Park Ha Biological Technology Co., Ltd.
Date: August 25, 2025	By:	/s/ Xiaoqiu Zhang
	Name:	Xiaoqiu Zhang
	Title:	Chief Executive Officer, Chairperson of the Board of Directors

2

FAQ

What board change did Park Ha Biological Technology Co., Ltd. (PHH) disclose in this 6-K?

The company disclosed that Mr. Da Yang resigned as an independent director of Park Ha Biological Technology Co., Ltd., effective August 25, 2025.

Did Mr. Da Yang resign from PHH due to a disagreement with the company?

No. The company states that Mr. Da Yang’s resignation was not a result of any disagreement with its operations, policies, or procedures.

When was the resignation of PHH independent director Mr. Da Yang effective?

The resignation of independent director Mr. Da Yang was effective on August 25, 2025.

Who signed the Park Ha Biological Technology Co., Ltd. (PHH) 6-K reporting the director’s resignation?

The report was signed on behalf of the company by Xiaoqiu Zhang, who serves as Chief Executive Officer and Chairperson of the Board of Directors.

What SEC form did PHH use to report the director’s resignation?

Park Ha Biological Technology Co., Ltd. reported the resignation on Form 6-K, which is used by foreign private issuers to furnish current information.